Treatment of UTI in Male Patients with Impaired Renal Function

Classification and Considerations

The European Urology guidelines consider UTIs in males as complicated UTIs, requiring more aggressive management and longer treatment duration 3
A recent history of instrumentation, such as lithotripsy, is an additional complicating factor 1

The European Urology guidelines recommend oral third-generation cephalosporin as the first-line option for stable, afebrile patients, with cefpodoxime 200mg twice daily and ceftibuten 400mg daily being suitable choices, both requiring renal dose adjustment 3, 4, 5
Trimethoprim-sulfamethoxazole 160/800mg twice daily, with renal dose adjustment, is an alternative option if beta-lactam allergy or local resistance patterns warrant 4
Ciprofloxacin 500mg twice daily may be used as an alternative option only if local resistance is less than 10% and the patient hasn't used fluoroquinolones in the past 6 months 1, 3

The European Urology guidelines recommend a 14-day treatment course for male UTIs when prostatitis cannot be excluded 1, 2
A shorter course of 7 days may be considered if the patient is hemodynamically stable, has been afebrile for at least 48 hours, and there are relative contraindications to longer antibiotic use 1, 2, 3

The microbial spectrum in complicated UTIs is broader than in uncomplicated UTIs, including common pathogens such as E. coli, Proteus spp., Klebsiella spp., Pseudomonas spp., Serratia spp., and Enterococcus spp. 1
Antimicrobial resistance is more likely in complicated UTIs 1
The European Urology guidelines recommend avoiding fluoroquinolones unless necessary, such as when local resistance rates exceed 10%, the patient has been treated in a urology department, or has used fluoroquinolones in the last 6 months 1, 2, 3

The European Urology guidelines recommend obtaining a urine culture to guide targeted therapy and considering switching to a pathogen-specific antibiotic once culture results are available 1